<b>Background:</b> High-grade gliomas, including isocitrate dehydrogenase (<i>IDH</i>)-mutant astrocytoma and <i>IDH</i> wild-type glioblastoma, have a poor prognosis and limited treatment options. This evidence concerns the gene IDH3A and astrocytoma (excluding glioblastoma).